Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D

NCT02607410 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: sitagliptin
DRUG: NPH insulin

Sponsor

University of Sao Paulo General Hospital

Collaborators

[object Object]